Search Results for

*

1-19 of 19 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Preventing or Delaying Type 2 Diabetes Mellitus with Diet and Exercise - Cochrane for ...

Dec 1, 2018 - There is moderate-quality evidence that in patients with impaired glucose tolerance (IGT) defined by an abnormal 75-g two-hour glucose tolerance test, implementing changes in diet and adding physical activity together can prevent or delay the development of type 2 diabetes.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2018/1201/p643.html

DPP-4 Inhibitors and GLP-1 Receptor Agonists for Prevention or Delay of Type 2 Diabetes...

Apr 1, 2018 - There is only limited-quality evidence that at-risk patients taking GLP-1 receptor agonists are less likely to progress to diabetes (number needed to treat [NNT] = 23). Serious adverse events were more likely in patients taking GLP-1 receptor agonists than in patients taking placebo ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2018/0401/p437.html

Insulin for Glycemic Control in Acute Ischemic Stroke - Cochrane for Clinicians - ...

Dec 1, 2012 - Administering insulin to maintain glycemic control does not improve the rates of mortality or dependency, or the final neurologic outcome after an acute ischemic stroke. Additionally, in randomized controlled trials, patients in the intervention groups (those under tight glycemic ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2012/1201/p1008.html

Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes Not Using Insulin - ...

May 1, 2012 - For patients who have had diabetes longer than one year and are not using insulin, evidence suggests that the benefit of self-monitoring of blood glucose in lowering A1C levels is small at six months and disappears by 12 months. Self-monitoring of blood glucose does not improve ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2012/0501/p866.html

Does Metformin Increase the Risk of Fatal or Nonfatal Lactic Acidosis? - Cochrane for ...

Nov 1, 2010 - In patients without standard contraindications to metformin therapy, metformin does not increase the risk of lactic acidosis.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2010/1101/p1068.html

Low Glycemic Index Diets for the Management of Diabetes - Cochrane for Clinicians - ...

Nov 1, 2009 - The low glycemic index diet (sometimes called a low glycemic load diet) lowered the A1C level by a weighted mean difference of 0.5 percent when compared with a high glycemic index (or glycemic load) diet. Fewer episodes of hypoglycemia occurred with a low glycemic index diet compared ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2009/1101/p941.html

Dipeptidyl-peptidase-4 Inhibitors for Treatment of Type 2 Diabetes - Cochrane for ...

Mar 1, 2009 - When used as monotherapy or in conjunction with metformin (Glucophage) or thiazolidinediones, the DPP-4 inhibitor sitagliptin (Januvia) decreases A1C levels by 0.7 percent, but there are no data on patient-oriented outcomes or long-term safety. Until more studies are completed, it ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2009/0301/p372.html

Are Long-acting Insulin Analogues Better Than Isophane Insulin? - Cochrane for ...

Feb 15, 2008 - Based on poor quality evidence, this review suggests that insulin glargine and insulin detemir have no advantage over isophane insulin in reducing A1C levels. In one study, isophane insulin reduced A1C levels slightly more than insulin detemir. However, patients on insulin glargine and ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2008/0215/p447.html

ACE Inhibitors vs. ARBs for Patients with Diabetic Kidney Disease - Cochrane for ...

Jul 1, 2007 - Studies comparing ACE inhibitors or ARBs with placebo found no mortality benefit in patients with diabetic kidney disease. A subgroup analysis of five studies (2,034 total patients) found that, when given at full or maximally tolerated doses, ACE inhibitors reduce all-cause mortality ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0701/p68.html

Does Pioglitazone Benefit Patients With Type 2 Diabetes? - Cochrane for Clinicians - ...

Oct 1, 2007 - Pioglitazone produces a reduction in A1C levels similar to that produced by other drugs. One trial found that although pioglitazone, used as an adjunct to other antihyperglycemic medications, may lead to a statistically significant reduction in morbidity and mortality in patients with ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/1001/p969.html

Alpha-glucosidase Inhibitors May Reduce the Risk of Type 2 Diabetes - Cochrane for ...

Aug 1, 2007 - The literature shows that acarbose can reduce the risk of type 2 diabetes in patients with impaired glucose tolerance or impaired fasting glucose. However, it is unclear whether the drug stops or delays the development of the disease or masks the diagnosis. There is no evidence that ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0801/p374.html

The Role of Exercise in Patients with Type 2 Diabetes - Cochrane for Clinicians - ...

Feb 1, 2007 - Regular exercise reduces A1C levels, adiposity, and triglyceride levels. However, no research has definitively proved a benefit of exercise on patient-oriented outcomes such as diabetes-related morbidity and mortality.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0201/p335.html

Antihypertensive Agents for Prevention of Diabetic Nephropathy - Cochrane for ...

Jul 1, 2006 - Angiotensin-converting enzyme (ACE) inhibitors are the only antihypertensive agents with proven effectiveness for the primary prevention of diabetic nephropathy (defined as an albumin excretion of less than 30 mg per day on three serial measurements) caused by type 1 or type 2 diabetes....

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/0701/p77.html

Are Alpha-glucosidase Inhibitors Effective for Control of Type 2 Diabetes? - Cochrane ...

Feb 1, 2006 - The use of alpha-glucosidase inhibitors has a modest effect on intermediate diabetes-control endpoints such as postprandial blood glucose, postprandial insulin levels, and A1C levels. There is no evidence, however, of improvement in mortality, morbidity, or quality of life. In ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/0201/p433.html

Short-Acting Insulin Analogues vs. Human Insulin for Diabetes - Cochrane for Clinicians...

Sep 1, 2005 - For patients with type 2 diabetes, regular insulin and short-acting insulin analogues are equally effective in the treatment of diabetes and in lowering A1C levels. For patients with type 1 diabetes, short-acting analogues produce a slightly greater reduction of A1C levels than regular ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0901/p805.html

Cochrane for Clinicians - Mar 1, 2005 - American Family Physician

Mar 1, 2005 - Treatment with betamimetics decreases the number of women with preterm labor who give birth within 48 hours, but it does not decrease the number of births within seven days. Limited evidence suggests that treatment with beta-mimetics does not decrease perinatal death or morbidity.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0301/p899a.html

Cochrane for Clinicians - Mar 1, 2005 - American Family Physician

Mar 1, 2005 - NPH insulin and metformin taken at bedtime appears to be the most favorable combination studied, but this conclusion is based on poor-quality, inconsistent studies that measure disease-oriented outcomes. There are no data on the effect of these drug combinations on patient-oriented ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0301/p899.html

Cochrane for Clinicians - Dec 1, 2004 - American Family Physician

Dec 1, 2004 - Combined evidence from two clinical trials of calcium supplementation lasting for several years revealed a reduced rate of recurrent colorectal adenoma. However, evidence is insufficient to recommend supplementation with dietary calcium for patients who have never had an adenoma.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/1201/p2109.html

Intensive Management of Gestational Diabetes - Cochrane for Clinicians - American ...

Jul 1, 2004 - Advertisement << Previous article Next article >> Jul 1, 2004 Issue Cochrane Briefs Am Fam Physician. 2004 Jul 1;70(1):84. Intensive Management of Gestational Diabetes Clinical Question Does intensive management of gestational diabetes improve outcomes? Evidence-Based Answer There is...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/0701/p84.html

Page  1

25 50 100 results per page